Status:
COMPLETED
Zinc Supplementation in Pediatric Sepsis
Lead Sponsor:
Mansoura University
Conditions:
Zinc in Pediatric Sepsis
Eligibility:
All Genders
2-5 years
Phase:
PHASE2
Brief Summary
a single blinded randomized controlled clinical trial that was conducted to evaluate the role of zinc supplementation in improving the outcome of infants and children with sepsis in pediatric intensiv...
Detailed Description
a single blinded randomized controlled clinical trial that was conducted to evaluate the role of zinc supplementation in improving the outcome of infants and children with sepsis in pediatric intensiv...
Eligibility Criteria
Inclusion
- 2- Pediatric patients who fulfill Pediatric Consensus criteria for definition of severe sepsis as 1) greater than or equal to 2 age-based systemic inflammatory response syndrome criteria, 2) confirmed or suspected invasive infection, and 3) cardiovascular dysfunction, acute respiratory distress syndrome, or greater than or equal to 2 organ system dysfunctions
Exclusion
- Infants and children with history of prematurity (\< 37 weeks), chronic cardiopulmonary disease, immunodeficiency, neuromuscular disease, surgical conditions and any other chronic medical condition.
- Those who are regularly taking vitamin or mineral supplementations
Key Trial Info
Start Date :
July 31 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2022
Estimated Enrollment :
72 Patients enrolled
Trial Details
Trial ID
NCT05366595
Start Date
July 31 2019
End Date
August 1 2022
Last Update
March 3 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mansoura University Children's Hospital
Al Mansurah, Egypt, 35511